Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | NQO1 | P15559 | 1/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | CASP6 | P55212 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.30 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.30 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4079852 | 0.94 | TNKS (0.35) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL22255992 | 0.89 | ALOX5 (0.36) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL24425465 | 0.88 | CDC14B (0.31) | — | |
| SCHEMBL24425488 | 0.87 | TNKS (0.31) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL18798580 | 0.86 | SMN1; SMN2 (0.31) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL13171185 | 0.86 | TNKS (0.35) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL24425496 | 0.86 | — | — | |
| SCHEMBL18799373 | 0.85 | TNKS (0.36) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL4083817 | 0.85 | TNKS (0.34) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL4089242 | 0.84 | TNKS (0.32) | TNKSPARP1TNKS2HDAC6PARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11335859-B2 | Compound, coating composition comprising same, and organic light emitting element comprising same | LG CHEM, LTD. | 2022-05-17 | — | — | US | disclosed |
| US-20200235320-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11335859-B2 | Compound, coating composition comprising same, and organic light emitting element comprising same | SEM1, CRY1, CD99 | TNKS 3857/4885PARP1 2568/4885TNKS2 4082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.